| 12378230 |
GLP-1 receptor agonists and uses thereof |
Scott W. Bagley, John M. Curto, David James Edmonds, Mark E. Flanagan, Kentaro Futatsugi +8 more |
2025-08-05 |
|
| 12331041 |
GLP-1 receptor agonists and uses thereof |
Scott W. Bagley, Edward L. Conn, John M. Curto, David James Edmonds, Mark E. Flanagan +7 more |
2025-06-17 |
|
| 12319669 |
GLP-1 receptor agonists and uses thereof |
Scott W. Bagley, John M. Curto, Matthew S. Dowling, David James Edmonds, Mark E. Flanagan +9 more |
2025-06-03 |
|
| 11858916 |
GLP-1 receptor agonists and uses thereof |
Scott W. Bagley, Edward L. Conn, John M. Curto, David James Edmonds, Mark E. Flanagan +7 more |
2024-01-02 |
$249,725,000 |
| 11802121 |
GLP-1 receptor agonists and uses thereof |
Scott W. Bagley, John M. Curto, Matthew S. Dowling, David James Edmonds, Mark E. Flanagan +9 more |
2023-10-31 |
$284,263,000 |
| 11512070 |
GLP-1 receptor agonists and uses thereof |
Scott W. Bagley, John M. Curto, Matthew S. Dowling, David James Edmonds, Mark E. Flanagan +9 more |
2022-11-29 |
$2,104,375,000 |
| 10934279 |
GLP-1 receptor agonists and uses thereof |
Scott W. Bagley, John M. Curto, David James Edmonds, Mark E. Flanagan, Kentaro Futatsugi +8 more |
2021-03-02 |
$1,471,575,000 |
| 10851081 |
GLP-1 receptor agonists and uses thereof |
Scott W. Bagley, John M. Curto, Matthew S. Dowling, David James Edmonds, Mark E. Flanagan +9 more |
2020-12-01 |
$390,003,000 |
| 10683281 |
GLP-1 receptor agonists and uses thereof |
Scott W. Bagley, John M. Curto, David James Edmonds, Mark E. Flanagan, Kentaro Futatsugi +8 more |
2020-06-16 |
$1,092,312,000 |
| 10676465 |
GLP-1 receptor agonists and uses thereof |
Scott W. Bagley, John M. Curto, David James Edmonds, Mark E. Flanagan, Kentaro Futatsugi +8 more |
2020-06-09 |
$602,135,000 |
| 10669259 |
GLP-1 receptor agonists and uses thereof |
Scott W. Bagley, John M. Curto, Matthew S. Dowling, David James Edmonds, Mark E. Flanagan +9 more |
2020-06-02 |
$395,652,000 |
| 10208019 |
GLP-1 receptor agonists and uses thereof |
Scott W. Bagley, John M. Curto, Matthew S. Dowling, David James Edmonds, Mark E. Flanagan +9 more |
2019-02-19 |
$915,842,000 |
| 9452999 |
Glucagon receptor modulators |
Mary Theresa Didiuk, Kevin James Filipski, Angel Guzman-Perez, Esther Cheng Yin Lee, Jeffrey Allen Pfefferkorn +2 more |
2016-09-27 |
$786,368,000 |
| 9073871 |
Glucagon receptor modulators |
Mary Theresa Didiuk, Kevin James Filipski, Angel Guzman-Perez, Esther Cheng Yin Lee, Jeffrey Allen Pfefferkorn +2 more |
2015-07-07 |
$320,116,000 |
| 9056834 |
Glucagon receptor modulators |
Mary Theresa Didiuk, Kevin James Filipski, Angel Guzman-Perez, Jeffrey Allen Pfefferkorn, Benjamin Dawson Stevens +1 more |
2015-06-16 |
$141,497,000 |
| 8933104 |
Glucagon receptor modulators |
Mary Theresa Didiuk, Kevin James Filipski, Angel Guzman-Perez, Jeffrey Allen Pfefferkorn, Benjamin Dawson Stevens +1 more |
2015-01-13 |
$137,387,000 |
| 8859591 |
Glucagon receptor modulators |
Mary Theresa Didiuk, Kevin James Filipski, Angel Guzman-Perez, Esther Cheng Yin Lee, Jeffrey Allen Pfefferkorn +2 more |
2014-10-14 |
$166,604,000 |
| 8809342 |
Glucagon receptor modulators |
Mary Theresa Didiuk, Kevin James Filipski, Angel Guzman-Perez, Jeffrey Allen Pfefferkorn, Benjamin Dawson Stevens +1 more |
2014-08-19 |
$274,835,000 |
| 8507533 |
Glucagon receptor modulators |
Mary Theresa Didiuk, Kevin James Filipski, Angel Guzman-Perez, Esther Cheng Yin Lee, Jeffrey Allen Pfefferkorn +2 more |
2013-08-13 |
$353,289,000 |
| 7202275 |
Malonamic acids and derivatives thereof as thyroid receptor ligands |
Yuan-Ching P. Chiang, Kimberly G. Estep |
2007-04-10 |
|
| 6924310 |
Malonamic acids and derivatives thereof as thyroid receptor ligands |
Yuan-Ching P. Chiang, Kimberly G. Estep |
2005-08-02 |
$211,477,000 |
| 6723744 |
Indole carboxylic acids as thyroid receptor ligands |
Yuan-Ching P. Chiang |
2004-04-20 |
$379,600,000 |
| 6664291 |
Malonamic acids and derivatives thereof as thyroid receptor ligands |
Yuan-Ching P. Chiang, Kimberly G. Estep |
2003-12-16 |
$278,129,000 |
| 6441015 |
Tetrazole compounds as thyroid receptor ligands |
Yuan-Ching P. Chiang |
2002-08-27 |
$152,025,000 |
